LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 57

Search options

  1. Article ; Online: Internally Stented Bioprosthetic Heart Valves Should Not Be Used Any More.

    Toggweiler, Stefan / Moccetti, Federico / Matt, Peter

    JACC. Cardiovascular interventions

    2023  Volume 16, Issue 5, Page(s) 555–557

    MeSH term(s) Humans ; Treatment Outcome ; Aortic Valve/diagnostic imaging ; Aortic Valve/surgery ; Heart Valve Prosthesis Implantation/adverse effects ; Bioprosthesis ; Heart Valve Prosthesis ; Prosthesis Failure ; Transcatheter Aortic Valve Replacement ; Prosthesis Design
    Language English
    Publishing date 2023-03-15
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2452157-7
    ISSN 1876-7605 ; 1936-8798
    ISSN (online) 1876-7605
    ISSN 1936-8798
    DOI 10.1016/j.jcin.2023.02.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Acute Pulmonary Edema During Impella RP Support: Too Much of a Good Thing.

    Moccetti, Federico / Bloch, Andreas / Toggweiler, Stefan / Cuculi, Florim

    Circulation. Heart failure

    2023  Volume 16, Issue 9, Page(s) e010745

    MeSH term(s) Humans ; Heart Failure/diagnosis ; Heart Failure/therapy ; Pulmonary Edema/diagnosis ; Pulmonary Edema/etiology ; Pulmonary Edema/therapy ; Shock, Cardiogenic/diagnosis ; Shock, Cardiogenic/etiology ; Shock, Cardiogenic/therapy ; Treatment Outcome ; Heart-Assist Devices/adverse effects ; Retrospective Studies
    Language English
    Publishing date 2023-07-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2429459-7
    ISSN 1941-3297 ; 1941-3289
    ISSN (online) 1941-3297
    ISSN 1941-3289
    DOI 10.1161/CIRCHEARTFAILURE.123.010745
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Basal Septal Bulge as Risk Factor for New Conduction Disorders After Transcatheter Aortic Valve Replacement.

    Koch, Tanja / Brunner, Stephanie / Moccetti, Federico / Wolfrum, Mathias / Toggweiler, Stefan

    JACC. Cardiovascular interventions

    2023  Volume 16, Issue 13, Page(s) 1701–1702

    MeSH term(s) Humans ; Transcatheter Aortic Valve Replacement/adverse effects ; Treatment Outcome ; Aortic Valve/diagnostic imaging ; Aortic Valve/surgery ; Aortic Valve Stenosis/diagnostic imaging ; Aortic Valve Stenosis/surgery ; Risk Factors ; Heart Valve Prosthesis ; Pacemaker, Artificial
    Language English
    Publishing date 2023-06-07
    Publishing country United States
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 2452157-7
    ISSN 1876-7605 ; 1936-8798
    ISSN (online) 1876-7605
    ISSN 1936-8798
    DOI 10.1016/j.jcin.2023.04.041
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Global Ischemia After Complicated Transcatheter Aortic Valve Replacement.

    Toggweiler, Stefan / Mury, Raymond / Wolfrum, Mathias / Moccetti, Federico

    JACC. Cardiovascular interventions

    2022  Volume 15, Issue 11, Page(s) 1181–1182

    MeSH term(s) Aortic Valve/diagnostic imaging ; Aortic Valve/surgery ; Aortic Valve Stenosis/diagnostic imaging ; Aortic Valve Stenosis/surgery ; Heart Valve Prosthesis ; Humans ; Ischemia/diagnostic imaging ; Ischemia/etiology ; Prosthesis Design ; Transcatheter Aortic Valve Replacement/adverse effects ; Treatment Outcome
    Language English
    Publishing date 2022-04-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2452157-7
    ISSN 1876-7605 ; 1936-8798
    ISSN (online) 1876-7605
    ISSN 1936-8798
    DOI 10.1016/j.jcin.2022.02.030
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Amplatzer or Figulla Flex II Occluder: a comparative study of outcomes after transcatheter patent foramen ovale closure.

    Toggweiler, Stefan / Moccetti, Federico / Conrad, Nina / Loretz, Lucca / Madanchi, Mehdi / Bossard, Matthias / Attiger-Toller, Adrian / Cuculi, Florim / Wolfrum, Mathias

    The Journal of invasive cardiology

    2024  Volume 36, Issue 4

    Abstract: Objectives: Percutaneous closure of a patent foramen ovale (PFO) for the prevention of recurrent paradoxical thromboembolic events has been shown to be safe and effective in randomized controlled trials. However, it remains uncertain if differences in ... ...

    Abstract Objectives: Percutaneous closure of a patent foramen ovale (PFO) for the prevention of recurrent paradoxical thromboembolic events has been shown to be safe and effective in randomized controlled trials. However, it remains uncertain if differences in the structure and design of the occluder devices impact the outcomes. The aim of this study was to compare results of percutaneous PFO closure using 2 widely used double-disc occluders.
    Methods: Consecutive patients who underwent percutaneous PFO closure with the Abbott Amplatzer occluder (APO) or the Occlutech Figulla-Flex-II occluder (OPO) at the Heart Center Lucerne between February 2017 and December 2022 were included in a registry. The primary endpoint was effective closure of the PFO, defined as a residual shunt grade 0 or 1, assessed by contrast echocardiogram at 6-month follow-up. Secondary endpoints included procedural efficacy/safety and major adverse cardiovascular events during the hospital stay and at 6-month follow-up.
    Results: One hundred ninety-three consecutive patients (mean age 51.7 ± 12.5 years; 39% women; Risk of Paradoxical Embolism (RoPE) score = 7, IQR = 6-8) underwent percutaneous PFO closure with the APO (120 patients, 62.2%) or the OPO (73 patients, 37.8%). Main indications for closure were crypotogenic stroke in 168 patients (87.1%) and peripheral embolism in 13 patients (6.7%). At baseline, right-to-left shunt (RLS) greater than or equal to grade 2 was present in 189 patients (97.9%). Immediate procedural success was 99.5%. In 1 patient, an air embolism occurred during positioning of the APO occluder with transient chest pain and electrocardiogram changes, but without further sequelae to the patient. At 6-month follow-up, effective closure was achieved in 185 patients (95.8%; APO: 96.6% vs OPO: 94.5%, P = .30). Rates of atrial fibrillation and recurrent thromboembolic events were 4.2 and 0.5%, respectively.
    Conclusions: PFO closure is safe and effective when performed with either the self-expanding Abbott Amplatzer or Occlutech Figulla Flex II PFO occluder.
    MeSH term(s) Humans ; Female ; Adult ; Middle Aged ; Male ; Foramen Ovale, Patent/diagnosis ; Foramen Ovale, Patent/surgery ; Foramen Ovale, Patent/complications ; Treatment Outcome ; Echocardiography ; Stroke/epidemiology ; Stroke/etiology ; Stroke/prevention & control ; Septal Occluder Device/adverse effects ; Thromboembolism/etiology ; Cardiac Catheterization/methods
    Language English
    Publishing date 2024-04-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1154372-3
    ISSN 1557-2501 ; 1042-3931
    ISSN (online) 1557-2501
    ISSN 1042-3931
    DOI 10.25270/jic/23.00291
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cerebral embolic protection during transcatheter aortic valve replacement: Insights from a consecutive series with the Sentinel cerebral protection device.

    Wolfrum, Mathias / Moccetti, Federico / Loretz, Lucca / Bossard, Matthias / Attiger, Adrian / Cuculi, Florim / Toggweiler, Stefan

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

    2023  Volume 102, Issue 2, Page(s) 339–347

    Abstract: Background: Growing interest in neuroprotection in transcatheter aortic valve replacement (TAVR) has catalyzed the development of cerebral protection systems (CPS).: Objectives: Report insights from consecutive real-world patients undergoing TAVR ... ...

    Abstract Background: Growing interest in neuroprotection in transcatheter aortic valve replacement (TAVR) has catalyzed the development of cerebral protection systems (CPS).
    Objectives: Report insights from consecutive real-world patients undergoing TAVR with the Sentinel-CPS.
    Methods: Patients with severe aortic stenosis undergoing TAVR from April 2019 to May 2022 were enrolled in a prospective registry. The reason for unsuccessful Sentinel-CPS deployment and the amount of debris captured by the filters were prospectively recorded.
    Results: The Sentinal CPS was successfully deployed in 330 patients (85%, Group 1). Deployment was not attempted, unsuccessful or only partially successful in 59 patients (15%, Group 2), caused by anatomical factors such as tortuosity, heavy calcification or small dimensions of radial or brachial artery in 46, technical aspects such as puncture failure or dissection in 5 or use of right radial access for the pigtail in 6. Debris was captured in 98% of patients in Group 1. In 40%, the amount of debris was graded moderate or extensive. Predictors for moderate/extensive debris were moderate/severe aortic calcification (OR 1.50, CI 1.05-2.15, p = 0.03), pre- and postdilatation (OR 1.97, CI 1.02-3.79, p = 0.04 and OR 1.71, CI 1.01-2.89, p = 0.048). The risk of stroke was numerically lower in patients who underwent TAVR with the Sentinel CPS (2.1 vs. 5.1%, respectively, p = 0.15). There was no stroke during CPS deployment, but one patient had a stroke immediately after device retrieval.
    Conclusions: The Sentinel-CPS was successfully deployed in 85% of patients. Predictors for moderate/extensive debris captured were moderate/severe aortic calcification, pre- and postdilatation.
    MeSH term(s) Humans ; Transcatheter Aortic Valve Replacement ; Aortic Valve/diagnostic imaging ; Aortic Valve/surgery ; Aortic Valve Stenosis/diagnostic imaging ; Aortic Valve Stenosis/surgery ; Aortic Valve Stenosis/etiology ; Treatment Outcome ; Stroke/etiology ; Embolic Protection Devices ; Risk Factors
    Language English
    Publishing date 2023-05-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1459995-8
    ISSN 1522-726X ; 1522-1946
    ISSN (online) 1522-726X
    ISSN 1522-1946
    DOI 10.1002/ccd.30697
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device.

    Wolfrum, Mathias / Handerer, Immanuel Justus / Moccetti, Federico / Schmeisser, Alexander / Braun-Dullaeus, Ruediger C / Toggweiler, Stefan

    BMC cardiovascular disorders

    2023  Volume 23, Issue 1, Page(s) 306

    Abstract: Background: The Sentinel cerebral embolic protection device (CEP) aims to reduce the risk of stroke during transcatheter aortic valve replacement (TAVR). We performed a systematic review and meta-analysis of propensity score matched (PSM) and randomized ...

    Abstract Background: The Sentinel cerebral embolic protection device (CEP) aims to reduce the risk of stroke during transcatheter aortic valve replacement (TAVR). We performed a systematic review and meta-analysis of propensity score matched (PSM) and randomized controlled trials (RCT) investigating the effect of the Sentinel CEP to prevent strokes during TAVR.
    Methods: Eligible trials were searched through PubMed, ISI Web of science databases, Cochrane database, and proceedings of major congresses. Primary outcome was stroke. Secondary outcomes included all-cause mortality, major or life-threatening bleeding, major vascular complications and acute kidney injury at discharge. Fixed and random effect models were used to calculate the pooled risk ratio (RR) with 95% confidence intervals (CI) and absolute risk difference (ARD).
    Results: A total of 4066 patients from 4 RCTs (3'506 patients) and 1 PSM study (560 patients) were included. Use of Sentinel CEP was successful in 92% of patients and was associated with a significantly lower risk of stroke (RR: 0.67, 95% CI: 0.48-0.95, p = 0.02. ARD: -1.3%, 95% CI: -2.3 - -0.2, p = 0.02, number needed to treat (NNT) = 77), and a reduced risk of disabling stroke (RR: 0.33, 95% CI: 0.17-0.65. ARD: -0.9%, 95% CI: -1.5 - -0.3, p = 0.004, NNT = 111). Use of Sentinel CEP was associated with a lower risk of major or life-threatening bleeding (RR: 0.37, 95% CI: 0.16-0.87, p = 0.02). Risk for nondisabling stroke (RR: 0.93, 95% CI: 0.62-1.40, p = 0.73), all-cause mortality (RR: 0.70, 95% CI: 0.35-1.40, p = 0.31), major vascular complications (RR: 0.74, 95% CI: 0.33-1.67, p = 0.47) and acute kidney injury (RR: 0.74, 95% CI: 0.37-1.50, p = 0.40) were similar.
    Conclusions: The use of CEP during TAVR was associated with lower risks of any stroke and disabling stroke with an NNT of 77 and 111, respectively.
    MeSH term(s) Humans ; Transcatheter Aortic Valve Replacement ; Aortic Valve/diagnostic imaging ; Aortic Valve/surgery ; Aortic Valve Stenosis/diagnostic imaging ; Aortic Valve Stenosis/surgery ; Aortic Valve Stenosis/complications ; Propensity Score ; Risk Factors ; Treatment Outcome ; Randomized Controlled Trials as Topic ; Stroke/etiology ; Stroke/prevention & control ; Embolic Protection Devices ; Intracranial Embolism/diagnostic imaging ; Intracranial Embolism/etiology ; Intracranial Embolism/prevention & control
    Language English
    Publishing date 2023-06-17
    Publishing country England
    Document type Meta-Analysis ; Systematic Review ; Journal Article
    ZDB-ID 2059859-2
    ISSN 1471-2261 ; 1471-2261
    ISSN (online) 1471-2261
    ISSN 1471-2261
    DOI 10.1186/s12872-023-03338-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Effect of Additionally Integrating Clinical Information Into the Brugada Algorithm.

    Moccetti, Federico / Brugada, Pedro / Tersalvi, Gregorio / Yadava, Mrinal / Latifi, Yllka / Berte, Benjamin / Kobza, Richard / Sticherling, Christian / Reichlin, Tobias

    JACC. Clinical electrophysiology

    2023  Volume 9, Issue 6, Page(s) 868–870

    Language English
    Publishing date 2023-02-22
    Publishing country United States
    Document type Letter
    ZDB-ID 2846739-5
    ISSN 2405-5018 ; 2405-500X ; 2405-500X
    ISSN (online) 2405-5018 ; 2405-500X
    ISSN 2405-500X
    DOI 10.1016/j.jacep.2022.12.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The Allegra transcatheter heart valve: Long-term clinical and echocardiographic outcomes.

    Wolfrum, Mathias / Moccetti, Federico / Conrad, Nina / Loretz, Lucca / Bossard, Matthias / Attiger-Toller, Adrian / Cuculi, Florim / Toggweiler, Stefan

    The Journal of invasive cardiology

    2023  Volume 35, Issue 12

    Abstract: Objectives: The Allegra-THV is a novel, self-expanding THV with supra-annular bovine leaflets. The valve is available in 3 different sizes and is delivered through an 18 French sheath. To determine the safety and efficacy of the Allegra transcatheter ... ...

    Abstract Objectives: The Allegra-THV is a novel, self-expanding THV with supra-annular bovine leaflets. The valve is available in 3 different sizes and is delivered through an 18 French sheath. To determine the safety and efficacy of the Allegra transcatheter heart valve (THV; Biosensors) for the treatment of severe aortic valve stenosis under real-world conditions.
    Methods: Consecutive patients undergoing transcatheter aortic valve replacement (TAVR) at the Heart-Centre Lucerne with the Allegra-THV were included. Echocardiographic data were collected at baseline, before discharge, and at 1-year follow-up; clinical outcomes were recorded for up to 3 years. Clinical endpoints were defined according to the definitions of the Valve-Academic-Research-Consortium.
    Results: One hundred-three patients (age 81 ± 7 years, 63% women) were enrolled. Median European System for Cardiac Operative Risk Evaluation II score was 4.1% (IQR 1.8%-4.2%). Mean aortic valve gradient was 6.9 ± 3.3 mm Hg and 7.7 ± 3.3 mm Hg, and an effective orifice area was 2.1 ± 0.5 cm2 and 2.0 ± 0.5 cm2 at 30 days and 1-year follow-up, respectively. More than mild paravalvular leak was observed in 2.0% of patients at 30 days and 3.3% at 1 year. At 1-year follow-up, 14.7% of patients required implantation of a new permanent pacemaker, 1 patient had endocarditis with an uneventful clinical course and good THV-function after antibiotic therapy, and no thrombosis, structural-valve-detoriation (SVD), or non-SVD had occurred. At 3-year follow-up, rates of all-cause and cardiovascular mortality were 31.4% and 18.8%, respectively.
    Conclusions: Transfemoral implantation of the Allegra-THV resulted in favorable clinical and echocardiographic outcomes at up to 3-year follow-up. Head-to-head randomized clinical trials are necessary to determine if the Allegra-THV valve performs as well as current generation valves.
    MeSH term(s) Humans ; Animals ; Cattle ; Female ; Aged ; Aged, 80 and over ; Male ; Heart Valves ; Echocardiography ; Terfenadine ; Catheters
    Chemical Substances fexofenadine (E6582LOH6V) ; Terfenadine (7BA5G9Y06Q)
    Language English
    Publishing date 2023-12-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1154372-3
    ISSN 1557-2501 ; 1042-3931
    ISSN (online) 1557-2501
    ISSN 1042-3931
    DOI 10.25270/jic/23.00163
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Chest pain and plaque rupture without high-sensitive troponin elevation.

    Moccetti, Federico / Bossard, Matthias / Kobza, Richard / Cuculi, Florim

    Cardiology journal

    2019  Volume 26, Issue 2, Page(s) 194–195

    MeSH term(s) Adult ; Biomarkers/blood ; Chest Pain/blood ; Chest Pain/diagnosis ; Chest Pain/etiology ; Coronary Angiography ; Coronary Vessels/diagnostic imaging ; Diagnosis, Differential ; Drug-Eluting Stents ; Electrocardiography ; Humans ; Male ; Percutaneous Coronary Intervention/methods ; Plaque, Atherosclerotic/blood ; Plaque, Atherosclerotic/complications ; Plaque, Atherosclerotic/diagnosis ; Plaque, Atherosclerotic/surgery ; Rupture, Spontaneous/complications ; Rupture, Spontaneous/diagnosis ; Rupture, Spontaneous/surgery ; Tomography, Optical Coherence ; Troponin I/blood
    Chemical Substances Biomarkers ; Troponin I
    Language English
    Publishing date 2019-04-26
    Publishing country Poland
    Document type Case Reports ; Journal Article
    ZDB-ID 2488680-4
    ISSN 1897-5593 ; 1897-5593
    ISSN (online) 1897-5593
    ISSN 1897-5593
    DOI 10.5603/CJ.2019.0040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top